cytarabine and mk 2206

cytarabine has been researched along with mk 2206 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CY; Hu, CY; Lai, YL; Lin, LI; Lin, YM; Lu, JW; Ou, DL; Tien, HF	1

Other Studies

1 other study(ies) available for cytarabine and mk 2206

Article	Year
MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine. Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:7 Topics: Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Cytarabine; Down-Regulation; Drug Synergism; G1 Phase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Myeloid Cell Leukemia Sequence 1 Protein; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; U937 Cells	2015

Article

Year

MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine.

Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:7

Topics: Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Cytarabine; Down-Regulation; Drug Synergism; G1 Phase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Myeloid Cell Leukemia Sequence 1 Protein; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; U937 Cells

2015